Human IgM antibody
Principal name
Human IgM antibody
Alternative names for Human IgM antibody
Human Immunoglobulin M
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Paraffin Sections (P), Flow Cytometry (F), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Agglutination (AGG), Immunoprecipitation (IP), Immunodiffusion (ID), Dot blot (Dot), Functional assay (FN), Lateral Flow (LF), Radioimmunoassay (R)
Background of Human IgM antibody
IgM normally constitutes about 10% of serum immunoglobulins. IgM antibody is prominent in early immune responses to most antigens and predominates in certain antibody responses such as 'natural' blood group antibodies. IgM (with IgD) is the major immunoglobulin expressed on the surface of B cells. The gene for the mu constant region contains four domains separated by short intervening sequences. Class specific anti immunoglobulin antibodies are useful for: The characterization of malignant B cell proliferations. All but acute lymphocytic leukemias share either surface or intra cytoplasmic Ig with an isotypic restriction, which suggest the monoclonal nature of the cell population. Most of the chronic lymphocytic leukemias, non Hodgkin lymphomas and Burkitt's lymphoma bear surface IgM, whereas plasmocytes from Waldenström's disease bear intracytoplasmic IgM. The other isotypes are less frequently found. On the other hand multiple myelomas are usually of the IgG or IgA type. Characterization of plasma cells in inflammatory conditions: Plasma cell typing can be of use for the classification of intestinal inflammatory conditions such as inflammatory bowel disease and allergic conditions. In the latter a specific increase in the number of IgE plasma cells can be demonstrated.
General readings
Franklin E.C.: Structure and function of immunoglobulins. Acta Endocrinol Suppl (Copenh). 1975;194:77-95.
Fuller JM, Keyser J.W.: Serum immunoglobulins after surgical operation. Clin Chem. 1975 May;21(6):667-71.
Balogh Z, Meretey K, Falus A, Bozsoky S.: Serological abnormalities in juvenile chronic arthritis: a review of 46 cases. Ann Rheum Dis. 1980 Apr;39(2):129-34.
Brinkmann V, Heusser CH.: T cell-dependent differentiation of human B cells into IgM, IgG, IgA, or IgE plasma cells: high rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE precursors. Cell Immunol. 1993 Dec;152(2):323-32.









Secondary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AM08145AC-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | APC | Hu | ICC/IF |
0.1 mg /
€400.00
|
| OriGene Technologies GmbH | |||||||
| AM08145BT-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | Biotin | Hu | E, ICC/IF |
0.5 mg /
€290.00
|
| OriGene Technologies GmbH | |||||||
| AM08145FC-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | FITC | Hu | ICC/IF |
0.5 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08145HR-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | HRP | Hu | E |
1 ml /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08145PU-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | Purified | Hu | C, Dot, E, ICC/IF, WB |
0.5 mg /
€230.00
|
| OriGene Technologies GmbH | |||||||
| AM08145RP-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG1 | SA-DA4 | PE | Hu | ICC/IF |
0.1 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08146AP-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | AP | Hu | E |
1 ml /
€330.00
|
| OriGene Technologies GmbH | |||||||
| AM08146BT-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | Biotin | Hu | E, ICC/IF |
0.5 mg /
€290.00
|
| OriGene Technologies GmbH | |||||||
| AM08146FC-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | FITC | Hu | ICC/IF |
0.5 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08146HR-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | HRP | Hu | E |
1 ml /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08146LE-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | Low Endotoxin | Hu | C, Dot, E, ICC/IF, WB |
0.1 mg /
€440.00
|
| OriGene Technologies GmbH | |||||||
| AM08146PU-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | Purified | Hu | C, Dot, E, ICC/IF, WB |
0.5 mg /
€230.00
|
| OriGene Technologies GmbH | |||||||
| AM08146RP-N | Human IgM (Mu chain specific) |
||||||
![]() |
Mouse | IgG3 | UHB | PE | Hu | F |
0.1 mg /
€310.00
|
| OriGene Technologies GmbH | |||||||
| AM08147PU-N | Human IgM (Mu chain, Fab-Region) |
||||||
![]() |
Mouse | IgG3 | UHB | Purified | Hu | E, FN, ICC/IF |
0.25 mg /
€280.00
|
| OriGene Technologies GmbH | |||||||
| AM32216FC-N | Human IgM |
||||||
![]() |
Mouse | IgG1 | ICL-931 | FITC | Hu | C, E |
1 ml /
€580.00
|
| OriGene Technologies GmbH | |||||||
| AM32216HR-N | Human IgM |
||||||
![]() |
Mouse | IgG1 | ICL-931 | HRP | Hu | C, Dot, E, R |
1 ml /
€670.00
|
| OriGene Technologies GmbH | |||||||
| AM32216PU-N | Human IgM |
||||||
![]() |
Mouse | IgG1 | ICL-931 | Purified | Hu | C, Dot, E, R |
1 ml /
€410.00
|
| OriGene Technologies GmbH | |||||||
| BM489 | Human IgM |
||||||
![]() |
Mouse | IgG | 47.2.E9 | Purified | Hu | E |
0.2 mg /
€460.00
|
| OriGene Technologies GmbH | |||||||
| BM490 | Human IgM |
||||||
![]() |
Rat | IgM | HM-7 | Aff - Purified | Hu | E |
0.5 mg /
€560.00
|
| OriGene Technologies GmbH | |||||||
| BM4072 | Human IgM |
||||||
![]() |
Mouse | IgG1 | DM3A3 | Purified | Hu | C, P |
0.2 mg /
€330.00
|
| OriGene Technologies GmbH | |||||||






